AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 2210311 — intervention group
Group type: COMPARATOR
Intervention: Placebo (aspartic acid)
Number of subjects: 568
Study 2210311 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium group
Number of subjects: 568
Study 6159256 — intervention group
Group type: EXPERIMENTAL
Intervention: aprotinin
Number of subjects: 257
Study 6159256 — intervention group
Group type: EXPERIMENTAL
Intervention: glucagon
Number of subjects: 257
Study 31599043 — intervention group
Group type: EXPERIMENTAL
Intervention: 25.2 g oral patiromer plus standard of care (SOC)
Number of subjects: 30
Study 31599043 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 30
Study 31651118 — intervention group
Group type: EXPERIMENTAL
Intervention: SIB-VMAT plus capecitabine
Number of subjects: 59
Study 31651118 — intervention group
Group type: COMPARATOR
Intervention: Standard arm (image-guided VMAT plus capecitabine)
Number of subjects: 59
Study 28188124 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive behavioral therapy for insomnia (CCBT‐I) as an adjunctive treatment
Number of subjects: 0
Study 26147760 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold acclimation (14-15 °C) for 10 days
Number of subjects: 8
Study 24295397 — intervention group
Group type: EXPERIMENTAL
Intervention: Road Map (RM) protocol-based lifestyle program, including 3-4 consultations by a practice nurse within one year.
Number of subjects: 240
Study 24295397 — intervention group
Group type: EXPERIMENTAL
Intervention: Road Map (RM) protocol-based lifestyle program.
Number of subjects: 240
Study 24295397 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 240
Study 21407129 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus intervention
Number of subjects: 699
Study 21407129 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic intervention
Number of subjects: 699
Study 19765280 — intervention group
Group type: EXPERIMENTAL
Intervention: ALARM International Program (AIP) intervention including educational outreach visits and facility-based maternal death reviews; duration: 2 years
Number of subjects: 46
Study 19765280 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 17577465 — intervention group
Group type: EXPERIMENTAL
Intervention: Parecoxib 40 mg BID
Number of subjects: 26
Study 17577465 — intervention group
Group type: COMPARATOR
Intervention: Dipyrone 1000 mg QID
Number of subjects: 26
Study 15684245 — intervention group
Group type: EXPERIMENTAL
Intervention: In-patient comprehensive geriatric assessment (CGA)
Number of subjects: 10427
Study 15684245 — intervention group
Group type: EXPERIMENTAL
Intervention: Ward-based management units
Number of subjects: 10427
Study 15684245 — intervention group
Group type: EXPERIMENTAL
Intervention: Team-based care
Number of subjects: 10427
Study 11278228 — intervention group
Group type: EXPERIMENTAL
Intervention: Earle's+AA
Number of subjects: 129
Study 11278228 — intervention group
Group type: EXPERIMENTAL
Intervention: K-SCIM
Number of subjects: 129
Study 11278228 — intervention group
Group type: COMPARATOR
Intervention: Earle's+Gln
Number of subjects: 129
Study 9874915 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambivalence about spouses
Number of subjects: 0
Study 9874915 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial grief and distress
Number of subjects: 0
Study 9874915 — intervention group
Group type: COMPARATOR
Intervention: Bereaved participants
Number of subjects: 0
Study 9279198 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilting at 20 degrees, 40 degrees, and 60 degrees
Number of subjects: 16
Study 9279198 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilting at 10 min and 45 min
Number of subjects: 16
Study 9279198 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-up tilting
Number of subjects: 16
Study 1827075 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 105
Study 1827075 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 105
Study 7036196 — intervention group
Group type: EXPERIMENTAL
Intervention: Isocarboxazid (Marplan) 20 mg daily, increased to achieve 90% platelet MAO inhibition
Number of subjects: 30
Study 7036196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31757473 — intervention group
Group type: EXPERIMENTAL
Intervention: Omission of gastric residuals
Number of subjects: 143
Study 31757473 — intervention group
Group type: COMPARATOR
Intervention: Prefeed gastric residuals
Number of subjects: 143
Study 30928020 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet treatment
Number of subjects: 69
Study 30928020 — intervention group
Group type: COMPARATOR
Intervention: TGF-β type I receptor (TβR I) inhibitor A83-01
Number of subjects: 69
Study 27384245 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained Lung Inflation (SLI)
Number of subjects: 112
Study 27384245 — intervention group
Group type: COMPARATOR
Intervention: Conventional Bag/Mask Inflation (CBMI)
Number of subjects: 112
Study 25378647 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl (low dose, 1/50th of rescue morphine dose)
Number of subjects: 51
Study 25378647 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl (high dose, 1/25th of rescue morphine dose)
Number of subjects: 51
Study 25378647 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study 25378647 — intervention group
Group type: COMPARATOR
Intervention: Oral morphine (active control)
Number of subjects: 51
Study 24421214 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentaerythrityl-tetranitrate (PETN)
Number of subjects: 111
Study 24421214 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 22561296 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementation with omega-3 polyunsaturated fatty acid (PUFA) and vitamins C and E
Number of subjects: 152
Study 22561296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study 19170908 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation (RF)
Number of subjects: 33
Study 17202547 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 46
Study 17202547 — intervention group
Group type: COMPARATOR
Intervention: ECT
Number of subjects: 46
Study 15203809 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion treatment
Number of subjects: 0
Study 15203809 — intervention group
Group type: EXPERIMENTAL
Intervention: Small lapses during treatment
Number of subjects: 0
Study 15203809 — intervention group
Group type: EXPERIMENTAL
Intervention: Small lapses during follow-up
Number of subjects: 0
Study 15203809 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between drug treatment and lapse history
Number of subjects: 0
Study 11943448 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous interleukin-2 (IL-2) plus antiretroviral therapy
Number of subjects: 4000
Study 11943448 — intervention group
Group type: COMPARATOR
Intervention: Antiretroviral therapy alone
Number of subjects: 4000
Study 8464953 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 lux light therapy
Number of subjects: 105
Study 8464953 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 lux light therapy
Number of subjects: 105
Study 8464953 — intervention group
Group type: EXPERIMENTAL
Intervention: 3500 lux light therapy
Number of subjects: 105
Study 8464953 — intervention group
Group type: EXPERIMENTAL
Intervention: All three intensities of light therapy
Number of subjects: 105
Study 3515509 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral rehydration salts (ORS) from effervescent tablets containing citrate
Number of subjects: 115
Study 3515509 — intervention group
Group type: COMPARATOR
Intervention: WHO recommended ORS
Number of subjects: 115
Study 3515509 — intervention group
Group type: COMPARATOR
Intervention: WHO ORS
Number of subjects: 115
Study 3515509 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate containing ORS
Number of subjects: 115
Study 30768195 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Ji Quan: Moving for Better Balance (TJQMBB)
Number of subjects: 670
Study 30768195 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal exercise
Number of subjects: 670
Study 30768195 — intervention group
Group type: COMPARATOR
Intervention: Stretching exercise
Number of subjects: 670
Study 29996817 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention to increase implementation of a healthy canteen policy
Number of subjects: 173
Study 27654733 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dexamethasone (0.1% eye drops)
Number of subjects: 108
Study 27654733 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-tenon triamcinolone injection (40mg/1ml)
Number of subjects: 108
Study 27654733 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 108
Study 25351352 — intervention group
Group type: EXPERIMENTAL
Intervention: Light meal (breakfast)
Number of subjects: 17
Study 22564997 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX), Cisplatin (CDP), Doxorubicin (ADM) with Ifosfamide (IFO) (arm B)
Number of subjects: 246
Study 22564997 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX), Cisplatin (CDP), Doxorubicin (ADM) without Ifosfamide (IFO) (arm A)
Number of subjects: 246
Study 22564997 — intervention group
Group type: EXPERIMENTAL
Intervention: Both arms (A and B)
Number of subjects: 246
Study 22564997 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm B (with IFO)
Number of subjects: 246
Study 20970749 — intervention group
Group type: EXPERIMENTAL
Intervention: Incentive spirometry (IS) for 10 breaths, 5 times per day
Number of subjects: 41
Study 20970749 — intervention group
Group type: COMPARATOR
Intervention: Incentive spirometry (IS) for 3 breaths, once per day (Control)
Number of subjects: 41
Study 18585771 — intervention group
Group type: EXPERIMENTAL
Intervention: Special training condition
Number of subjects: 16
Study 18585771 — intervention group
Group type: COMPARATOR
Intervention: Standard training condition
Number of subjects: 16
Study 16042234 — intervention group
Group type: EXPERIMENTAL
Intervention: MS group (patients with MS)
Number of subjects: 100
Study 16042234 — intervention group
Group type: COMPARATOR
Intervention: Cane‐assisted group
Number of subjects: 100
Study 16042234 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonassisted group
Number of subjects: 100
Study 16042234 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 healthy subjects)
Number of subjects: 100
Study 12415457 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate feeding (within 1 hour)
Number of subjects: 80
Study 12415457 — intervention group
Group type: COMPARATOR
Intervention: Next-day feeding (24 hours after procedure)
Number of subjects: 80
Study 10606453 — intervention group
Group type: EXPERIMENTAL
Intervention: External beam irradiation (seven treatment sessions)
Number of subjects: 73
Study 10606453 — intervention group
Group type: COMPARATOR
Intervention: Sham radiation (one sham treatment session)
Number of subjects: 73
Study 10606453 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 73
Study 8948386 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat bran concentrate bread products
Number of subjects: 8
Study 8948386 — intervention group
Group type: COMPARATOR
Intervention: Control white bread
Number of subjects: 8
Study 2059103 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric stimulation
Number of subjects: 59
Study 2059103 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 59
Study 6381884 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemo-hormonal regimen for first recurrence
Number of subjects: 194
Study 6381884 — intervention group
Group type: EXPERIMENTAL
Intervention: Entire group
Number of subjects: 194
Study 31477558 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily for 8 weeks (run-in phase)
Number of subjects: 3494
Study 31477558 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg or 300 mg or matched placebo (double-blind randomisation)
Number of subjects: 3494
Study 29972709 — intervention group
Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 52
Study 29972709 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 52
Study 27049446 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi exercise (n = 22)
Number of subjects: 43
Study 27049446 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 21)
Number of subjects: 43
Study 25172777 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg
Number of subjects: 641
Study 25172777 — intervention group
Group type: COMPARATOR
Intervention: Control (no doxycycline)
Number of subjects: 641
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamed intramedullary nailing
Number of subjects: 1226
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Stainless steel nail
Number of subjects: 1226
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Fracture gap
Number of subjects: 1226
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Full weight-bearing status after surgery
Number of subjects: 1226
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamed nailing
Number of subjects: 1226
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreamed nailing
Number of subjects: 1226
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound management without additional procedures
Number of subjects: 1226
Study 23032589 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound management with delayed primary closure
Number of subjects: 1226
Study 20977368 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid 600 mg
Number of subjects: 16
Study 20977368 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 750 mg
Number of subjects: 16
Study 17692271 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (500 mg tablet daily)
Number of subjects: 52
Study 17692271 — intervention group
Group type: COMPARATOR
Intervention: Acyclovir (400 mg tablet twice daily)
Number of subjects: 52
Study 15679567 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured intervention exercise program (one session per week, 90 min, for 1 year)
Number of subjects: 117
Study 15679567 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up program or other programs of the same club (after initial 12 months)
Number of subjects: 117
Study 15679567 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified intervention)
Number of subjects: 117
Study 11953546 — intervention group
Group type: COMPARATOR
Intervention: Functional Electric Stimulation (FES) therapy for short-duration hemiplegia, 6 hours a day for 6 weeks.
Number of subjects: 0
Study 11953546 — intervention group
Group type: COMPARATOR
Intervention: Functional Electric Stimulation (FES) therapy for long-duration hemiplegia, 6 hours a day for 6 weeks.
Number of subjects: 0
Study 11953546 — intervention group
Group type: COMPARATOR
Intervention: Second 6-week FES therapy after the first 6-week therapy for both short and long-duration groups.
Number of subjects: 0
Study 9525433 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoxynol-9 (N-9) 100 mg daily for 1 week
Number of subjects: 40
Study 9525433 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 7650839 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine
Number of subjects: 19
Study 7650839 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-carnitine
Number of subjects: 19
Study 7650839 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 2676652 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg fenticonazole (single administration)
Number of subjects: 80
Study 2676652 — intervention group
Group type: COMPARATOR
Intervention: 500 mg clotrimazole (single administration)
Number of subjects: 80
Study 803977 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 hr fast
Number of subjects: 9
Study 803977 — intervention group
Group type: EXPERIMENTAL
Intervention: 36 hr fast
Number of subjects: 9
Study 30584131 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Arginine supplementation
Number of subjects: 10
Study 30584131 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 29081128 — intervention group
Group type: EXPERIMENTAL
Intervention: High pressure oxygen and Butylphthalide
Number of subjects: 84
Study 29081128 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy and high pressure oxygen (Control)
Number of subjects: 84
Study 25935844 — intervention group
Group type: EXPERIMENTAL
Intervention: J‐Tip (lidocaine)
Number of subjects: 205
Study 25935844 — intervention group
Group type: COMPARATOR
Intervention: Vapocoolant spray (control)
Number of subjects: 205
Study 25935844 — intervention group
Group type: COMPARATOR
Intervention: Vapocoolant spray and pop of an empty J‐Tip (sham)
Number of subjects: 205
Study 22537562 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 15
Study 22537562 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 15
Study 19681772 — intervention group
Group type: EXPERIMENTAL
Intervention: LMA Supreme
Number of subjects: 138
Study 19681772 — intervention group
Group type: COMPARATOR
Intervention: ETT
Number of subjects: 138
Study 19079970 — intervention group
Group type: EXPERIMENTAL
Intervention: Preimplantation genetic screening (PGS)
Number of subjects: 200
Study 19079970 — intervention group
Group type: COMPARATOR
Intervention: Conventional assisted reproduction treatment (Control)
Number of subjects: 200
Study 15823628 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment with diet, anti-hypertensive or antidiabetic drugs
Number of subjects: 238
Study 15823628 — intervention group
Group type: COMPARATOR
Intervention: Control group referred to general practitioner
Number of subjects: 238
Study 12092978 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant mixture (vitamin E, beta-carotene, ascorbic acid, selenium, alpha-lipoic acid, N-acetyl 1-cysteine, catechin, lutein, lycopene)
Number of subjects: 40
Study 12092978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 10709527 — intervention group
Group type: EXPERIMENTAL
Intervention: Procera system (titanium copings veneered with a low‐fusing ceramic)
Number of subjects: 18
Study 10709527 — intervention group
Group type: COMPARATOR
Intervention: Noble-alloy copings veneered with a medium‐fusing ceramic
Number of subjects: 18
Study 8746880 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg estriol vaginal suppositories
Number of subjects: 72
Study 8746880 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 mg estriol vaginal suppositories
Number of subjects: 72
Study 1974723 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulphasalazine
Number of subjects: 200
Study 1974723 — intervention group
Group type: COMPARATOR
Intervention: Penicillamine
Number of subjects: 200
Study 6167093 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute excision and grafting in the shock-phase
Number of subjects: 0
Study 6167093 — intervention group
Group type: COMPARATOR
Intervention: Exposure for about 14 days, followed by excision and grafting
Number of subjects: 0
Study 28779007 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 68
Study 28779007 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone implants
Number of subjects: 68
Study 28779007 — intervention group
Group type: EXPERIMENTAL
Intervention: Central macular thickness change
Number of subjects: 68
Study 29944242 — intervention group
Group type: EXPERIMENTAL
Intervention: E2 supplementation during the luteal phase
Number of subjects: 100
Study 29944242 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 24757918 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fidelity simulation (HFS)
Number of subjects: 33
Study 24757918 — intervention group
Group type: COMPARATOR
Intervention: Traditional static mannequins
Number of subjects: 33
Study 22648841 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 0
Study 22648841 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIC + Enteral Nutrition (HIIC+EN)
Number of subjects: 0
Study 22648841 — intervention group
Group type: EXPERIMENTAL
Intervention: HIIC + Parenteral Nutrition (HIIC+PN)
Number of subjects: 0
Study 20931801 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive drospirenone/ethinyl E2 (group 1)
Number of subjects: 120
Study 20931801 — intervention group
Group type: EXPERIMENTAL
Intervention: Norelgestromin/ethinyl E2 transdermal patch (group 2)
Number of subjects: 120
Study 20931801 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal ring etonogestrel/ethinyl E2 (group 3)
Number of subjects: 120
Study 18408604 — intervention group
Group type: EXPERIMENTAL
Intervention: Slow-velocity (S: 30 degrees.s(‐1))
Number of subjects: 16
Study 18408604 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast-velocity (F: 210 degrees.s(‐1))
Number of subjects: 16
Study 18408604 — intervention group
Group type: COMPARATOR
Intervention: 30 maximal lengthening contractions
Number of subjects: 16
Study 18408604 — intervention group
Group type: COMPARATOR
Intervention: 210 maximal lengthening contractions
Number of subjects: 16
Study 15909743 — intervention group
Group type: EXPERIMENTAL
Intervention: PET
Number of subjects: 17
Study 15909743 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI
Number of subjects: 17
Study 15909743 — intervention group
Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 17
Study 12743232 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (IFNbeta-1b)
Number of subjects: 0
Study 10319572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed advice intervention (individualized letters sent to subjects)
Number of subjects: 226
Study 10319572 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed advice intervention
Number of subjects: 226
Study 10319572 — intervention group
Group type: COMPARATOR
Intervention: Control group (no mailed advice)
Number of subjects: 226
Study 8571209 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Sugiura procedure
Number of subjects: 54
Study 8571209 — intervention group
Group type: COMPARATOR
Intervention: Portal systemic shunt
Number of subjects: 54
Study 2020272 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (20 mg)
Number of subjects: 10